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Abstract
Background 
Patient-directed knowledge tools such as patient versions of guidelines and patient decision 
aids are increasingly developed to facilitate shared decision-making. In this paper, we report how 
consensus was reached within the Netherlands on quality criteria for development, content and 
governance of these tools 
Method
A 12-month development and consensus study. The consortium worked on four work packages: 
1/ reviewing existing criteria; 2/ drafting the quality criteria; 3/ safe-guarding the acceptability 
and feasibility of the draft criteria by participatory research in ongoing tool development 
projects; and 4/ gaining formal support from national stakeholders on the quality criteria. 
Results
We reached consensus on an 8-step guidance; describing minimal quality criteria for 1/ the team 
composition, 2/ setting the scope, 3/ identifying needs, 4/ the content and format, 5/ testing 
the draft, 6/ finalising and approval, 7/ dissemination and application, and 8/ ownership and 
revision. The participants of the ongoing tool development projects were positive about the 
quality criteria in general, but divided as to the degree of detail. Whereas some expressed a clear 
desire for procedural standards, others felt that it would be sufficient to provide only general 
directions. Despite the different views as to the degree of detail, consensus was reached in three 
stakeholder meetings. 
Discussion
We successfully collaborated with all stakeholders and achieved formal support from national 
stakeholders on a set of minimum criteria for the development process, content and governance 
of patient-directed knowledge tools.
Keywords 
patient participation, patient involvement, shared decision-making, clinical practice guidelines, 
quality standards, patient decision aids, patient information, patient versions of guidelines
Valorisation chapter
DunjaDreesens_binnenwerk_def_aangepast.indd   172 25-9-2020   00:42:31
173
Introduction
The knowledge in health care is expanding daily – so that keeping up with knowledge is a 
challenge1. The development of knowledge tools is intended to support clinicians to keep 
pace and to improve their decision-making. Many knowledge tools such as clinical practice 
guidelines, protocols, or clinical pathways have been developed over the years2. With the 
increasing call for a patient revolution3, further tool types have been added to the mix, including 
patient decision aids. A key source of information for patient-directed knowledge tools is clinical 
practice guidelines. Clinical practice guidelines summarize research evidence systematically 
and provide recommendations on a specific clinical topic4. Nowadays, the GRADE approach 
is used as a framework to rate the quality of the evidence, and to assess the strength of the 
recommendations taking into account the balance between benefits and harms, resource 
use, and feasibility considerations. The GRADE method also recognises the collective 
patient perspectives5; the strength of the recommendations is also affected by the patients’ 
appreciation of advantages and level of acceptability of disadvantages of the intervention, 
such as side effects and treatment burden. Worldwide, patients and patient representatives 
increasingly take part in the development of guideline recommendations6. 
Next to patient participation on a collective level, efforts are made to adapt or enrich guidelines 
so as to facilitate patient participation on an individual level, in clinical decision-making7. Patient 
participation is especially important in case of preference-sensitive decisions where multiple 
options exist, or where the benefits and harms of the intervention may be assigned a different 
weight by different patients8. Illustrative examples to facilitate patient participation in clinical 
decision-making are patient versions of a guideline such as a lay summary, or patient decision 
aids for specific preference-sensitive decisions attached to the guideline document. Some 
guidance for content of lay summaries of guidelines is provided by the Guidelines International 
Network9. In 2006, standards were formulated for the content of patient decision aids by the 
International Patient Decision Aids Standards (IPDAS) group, a multi-stakeholder process that 
led to a self-assessment checklist10. Further work led to a measure IPDASi11 and a set of criteria 
that should be met to achieve a ‘minimum’ acceptable standard12. Guideline developers are 
experimenting to derive the information for patient decision aids – evidence on benefits and 
harms of interventions and on patient considerations and patient preferences – directly from the 
guideline13.
Much is also happening with respect to the development of patient-centred knowledge tools 
such as patient versions of a guideline or patient decision aids in the Netherlands, on various 
sides of the care equation14. Patient organisations are gaining a more accurate picture of the 
information needs that these tools must satisfy. Professional and scientific associations feel a 
responsibility to ensure the accuracy and effectiveness of medical information supplied via such 
tools. Web and tool designers continue to introduce ever more user-interface friendly tools.
For this study, we used the following definition: a patient-directed knowledge tool synthesizes 
and distils the highest quality knowledge and research, is aimed directly at the patient (and next 
of kin), with the goal to engage patients in dialogue or deliberation during a clinical encounter, 
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or to support and/or improve patient decision making which may or may not take place during 
a clinical encounter15. Yet these patient-centred knowledge tools are subject to a multitude 
of varying definitions and criteria, especially regarding the patient versions of guidelines, and 
the development process16-22. As a result, it is difficult for parties to distinguish what is truly 
important from what is not, or what type of patient-directed knowledge tool is in fact the 
correct means to achieve the stated purpose. In addition to quality criteria, the need for national 
governance is also felt strongly, as many initiatives by patient organisations and professional 
bodies to develop patient-directed knowledge tools exist side by side. This situation has 
resulted in an uncoordinated, partly overlapping mixture of publicly and privately/commercially 
available patient decision aids23. Moreover, some of the patient decision aids do not seem to 
follow the rigid and multi-stakeholder methods to review the evidence base, as is common in 
clinical practice guidelines. 
A guidance for the development of reliable patient versions of guidelines and patient decision 
aids can serve to integrate all existing knowledge and previously developed expertise, allowing 
the stakeholders to work together more effectively and more efficiently. The purpose of such a 
guidance is to promote the development of high-quality, reliable and publicly available patient-
directed knowledge tools, which will contribute to achieving properly informed patients and 
shared decision-making.
Initiated by the National Health Care Institute of the Netherlands, a consortium of healthcare 
stakeholders started to develop such guidance, supported by academic researchers. Apart from 
validity, feasibility was important given the conflict between the aim of high-quality knowledge 
tools and the limited resources to develop such tools. The purpose of this article is twofold. 
First, we describe the methods used for arriving at the guidance as an illustrative example of 
how formal support from national stakeholders can be reached. Second, we present the list 
(guidance) of minimum quality criteria for the development, content and governance of patient 
information on guidelines and patient decision aids, as well as the way in which these tools can 
be connected to the clinical practice guidelines. 
Methods
The National Health Care Institute of the Netherlands initiated and granted this 12-month 
development study, that was composed of a literature review, a feasibility check, and a 
consensus procedure. We took the position that we needed various types of input and 
processes to ensure a successful consensus process. To this end, we designed a consortium 
(see first four authors and last two authors) that worked together continuously in an iterative 
process using cross-fertilisation, without being hindered by hierarchy. A representative of the 
Dutch Federation of Patients’ Organisations (last author) was co-leading the project with the 
first author.
In a 12-month project that started in October 2015, we worked on the basis of four work 
packages (WPs): WP1/ Radboud University (MF) reviewed existing criteria in the literature, 
synthesising evidence and best practices; WP2/ Maastricht University (TvdW, DD), the 
coordinating group, developed the drafts of the guidance; WP3/ NIVEL (NB) safeguarded 
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the acceptability and feasibility of the draft criteria by gathering experiences with the 
draft guidance from knowledge tool developers; WP4/ the Dutch Federation of Patients’ 
Organisations (AK) organised the consensus procedure aiming to support the guidance by 
national stakeholders.
Work package 1 
We searched for formal criteria and methodologies in the scientific literature, in policy reports, 
and on websites by developers of guidelines and patient decision aids. The search strings 
that we used to explore PubMed are described in Table 1, as are the websites to search for 
the grey literature. This inventory supplied the basis for the first draft of the guidance. One of 
the researchers of WP1 made a first selection of the search based on title and abstract, and 
excluded references clearly not fulfilling the inclusion criteria. All full-text versions that resulted 
from this first selection were downloaded and assessed along the pre-set in- and exclusion 
criteria. In case of doubt a second researcher was consulted to reach consensus on in- or 
exclusion.
Inclusion criteria for literature on patient versions of guidelines:
 - The paper describes the development process of a patient version or lay summary of a 
clinical practice guideline. 
 - Explicit description of the methods used (be it short or extensive) for development. 
 - English or Dutch language. 
Exclusion criteria:
 - Papers describing only the process of patient participation in development of a clinical 
practice guideline. 
Inclusion criteria for literature on patient decision aids: 
 - The title reports the term ‘development’ or ‘design’. 
 - The abstract reports the development of a patient decision aid as the aim of the paper. 
 - Description of development process of disease specific or generic decision aids. 
 - Explicit description of the methods used (be it short or extensive) for development. 
 - English or Dutch language. 
Exclusion criteria:
 - Papers describing development of tools that stretch further than patient decision aids (e.g. 
social support, self-management). 
 - Papers describing development of tools on other decisions than medical decisions.
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Table 1: Search strings used to explore Pubmed, and websites used to search for grey literature
Search strings
Patient information based on guidelines
 - (((method*[Title/Abstract] OR approach*[Title/Abstract] OR framework[Title/Abstract] OR 
develop*[Title/Abstract] OR creat*[Title/Abstract])) AND (“patient version*”[Title/Abstract] OR 
“information for the public”[Title/Abstract] OR “public information”[Title/Abstract] OR “patient 
booklet*”[Title/Abstract] OR booklet*[Title/Abstract])) AND (“clinical practice guideline*” OR “Practice 
Guidelines as Topic”[Mesh] OR “quality standard*”)
 - (“Practice Guidelines as Topic”[Mesh] OR “Practice Guideline” [Publication Type] OR guideline*) AND 
“patient version” AND develop*
 - Patient decision aids
 - “Decision Support Techniques”[Majr:NoExp] AND (method*[tiab] OR approach*[tiab] OR 
framework[tiab] OR develop*[tiab] OR creat*[tiab]) AND (“Patient Satisfaction”[Mesh] OR “Patient 
Participation”[Mesh] OR “Patient-Centered Care”[Mesh]))
Websites
 - Dutch Knowledge Institute of Medical Specialists
 - Netherlands Comprehensive Cancer Organisation
 - Guidelines International Network, Patient and Public Involvement working group
 - UK National Institute for Health and Care Excellence (NICE)
 - German Ärztliches Zentrum für Qualität in der Medizin (ÄZQ)
 - Finnish Duodecim
 - Australian National Health and Medical Research Council (NHMRC)
 - USA Oncoline Kaiser
 - USA Agency for Healthcare Research and Quality (AHRQ)
 - Canadian Task Force on Preventive Health Care (CTFPHC)
 - IPDAS working Group www.ipdas.ohri.ca
 - Patient Decision Aids Research Group https://decisionaid.ohri.ca
 - The Preference Laboratory http://optiongrid.org/option-grids/about-the-grids
 - Mayo Clinic for shared decision making http://shareddecisions.mayoclinic.org
 - DECIDE research Group www.decide-collaboration.eu
 - Joanna Briggs Institute University of Adelaide http://joannabriggs.org 
Work package 2
The project was coordinated via monthly meetings with all WP leaders, complemented by 
numerous one-to-one contacts. We used definitions of the patient-directed knowledge tools 
that were recently formulated in another Dutch national consensus procedure; see Box24-25.
 
The 
findings from the literature review were used to draft the first set of the minimal quality criteria 
for development, content and governance of patient-directed knowledge tools. The findings of 
the feasibility checks (WP3) and consensus meetings (WP4) were used to write the second and 
third draft of the guidance. 
Box 1: The Dutch definitions of the patient-directed knowledge tools.24-25
Patient information based on a guideline (= patient version of a 
guideline): Explanation of a specific condition or (health) care issue 
based on a guideline; made available to patients and their next of kin; 
provides information on available care choices and the care that they 
can expect from the care process. 
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Summary of guideline: Concise overview of the guideline, providing 
main conclusions and recommendations in clear and simple language; 
can be applied in practice independently from the guideline; intended 
for both care providers and patients.
Patient decision aid (PDA): Auxiliary information and answers to 
frequently asked questions for patients when choosing, with their 
care providers, from different options – including the option to forgo 
care – in a specific area such as diagnostics, treatment, screening, 
counselling or aftercare; discusses the possible outcomes and 
effects of each option – desirable or otherwise – and their likelihood 
of occurring; helps patients to weigh up their options based on their 
own values, standards and personal circumstances.
Work package 3
The first and second draft guidance was presented for a critical assessment of its feasibility 
to the project leaders of nine working groups tasked with the development of patient versions 
of guidelines or patient decision aids along clinical practice guidelines. These working groups 
were at that time in various phases of their development projects. Five projects focused 
on developing patient information based on guidelines, e.g. for patients with inflammatory 
bowel disease. Four projects focused on developing patient decision aids for specific 
recommendations, e.g. in the care for orthopaedic patients. For the third draft of the guidance 
we did not only seek for critical assessment by the project leader, but we also asked the project 
leader to actually apply (part of) the guidance steps in their working groups and to report 
about their experiences. Four of these nine ongoing projects were further analysed by means 
of outreach visits and participatory observations of working group meetings. Finally, the last 
draft and the experiences were fed back to each project leader in individual semi-structured 
qualitative interviews. The interviews were audiotaped, transcribed and analysed with thematic 
content analysis26.
Work package 4 
The draft versions of the guidance were discussed in three invitational meetings. We 
purposefully sampled the participants for the first two meetings to guarantee continuity in the 
process by inviting a core group for both meetings. While we planned the input from academic 
experts in the first meeting, the profile of participants gradually shifted to stakeholders 
representing end-users only in the last meeting. 
First, a two-hour expert meeting was held in March 2016 aimed at collecting the experts’ 
suggestions, for which 43 stakeholders representing patients, care providers, researchers, 
web and tool designers and healthcare insurers were invited. Second, a two-hour meeting was 
held in June 2016, for which 29 stakeholders representing patients, care providers, knowledge 
institutions, healthcare insurers and the government were invited to question their support to 
the draft version of the guidance. Third and finally, a 90-minute consensus meeting was held in 
September 2016, for which only the formal representatives of patients, healthcare providers and 
healthcare insurers were invited in order to gain formal support. 
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Results
How did we arrive at the guidance?
WP1 Inventory of existing methods and criteria in scientific and grey literature 
We found 51 hits in PubMed, of which four studies were included that describe criteria for 
developing patient versions of guidelines. The grey literature revealed many websites publishing 
patient versions of guidelines, but information on how these knowledge tools were developed 
was scarce. Detailed descriptions were found, however, in the Guidelines International Network 
‘GIN Public toolkit on patient and public involvement in guidelines’. For developing patient 
decision aids, we found 385 hits in PubMed, of which 24 studies were included; 10 more relevant 
publications were added by the experts in the project group. In addition, the websites revealed 
rich data on what exactly patient decision aids are and how they should be developed. 
The criteria for the content of patient decision aids were mostly based on empirical data26, 
while such data were more or less absent for the content of patient versions of guidelines.  
IPDAS criteria (ipdas.ohri.ca) enjoy broad support where criteria for the content of decision aids 
are concerned, due to their substantiation by means of systematic consensus methodology. 
WP3 Feasibility assessment in ongoing development projects
While reactions to the ordering of the development steps in the draft guidance were 
unanimously positive, the project leaders were extremely divided as to the degree of detail 
when it came to the instructions within the steps of the guidance, such as how best to map 
the patient perspective in the scoping and needs assessment phase. Whereas some project 
leaders expressed a clear desire for procedural standards (it should be clear at all times who 
does what and when), others felt that it would be sufficient for the instructions in each step 
to provide only general direction. Concerning the other issues raised, we report those most 
frequently mentioned:
 - Deviating from the linear ordering of the guidance should be possible. For example, the 
guideline working group may be no longer active, while the patient-directed tool is urgently 
needed.
 - Language and jargon used in the guidance was often found to be too academic.
 - The amount and complexity of the work to map the patients’ perspective in the scoping and 
needs assessment phase, e.g. by organising a focus group or a questionnaire survey, was 
often underestimated. Due to limitations in resources and the high workload, work should 
not be done twice, in the guideline working group and in the patient tool development group. 
Moreover, the required minimum number of two patients in the team - as was prescribed in 
the earlier drafts - was a concern, as well as the mandatory inclusion of a representative of 
the guideline working group.
 - Formal authorisation of the tool was not regarded necessary by all stakeholders, with the 
argument that the guideline was already approved.
 - All project leaders plead for a central portal to host the patient directed knowledge tools, 
supported by a national party taking care of the governance of the tools.
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WP4 The consensus meetings
For the first meeting, 28 out of 43 invited experts were present. When asked to mark the most 
important sections of the guidance, experts prioritised the following issues: chose the right 
type of knowledge tool for the aim it pursues; use the guideline (recommendation) itself as 
the most important source of information for the knowledge tool; determine who will become 
the owner of the knowledge tool; make the knowledge tool easily accessible and free to use; 
organize authorization by the healthcare professional organization(s) as well as the patients’ 
organization(s).
For the second meeting 21 out of 29 invited were present. All stakeholders were well 
represented. In general, they expressed a positive attitude towards the guidance although two 
critical remarks were made. Firstly, multiple stakeholders emphasized to widen the scope of 
the guidance so that patient-directed knowledge tools can also be developed on topics that 
are not covered by clinical practice guidelines; especially patient organizations claimed that 
the information needs of patients should determine the content of patient-directed knowledge 
tools, as opposed to only following the existing guideline recommendations. Secondly, the 
nursing organisation criticized the language of the guidance being too scientific and loaded with 
too much medical jargon.
The third meeting was attended by formal representatives of all parties except for the Dutch 
Association of Insurers, which formally declined while giving blind consent to the guidance 
as a token of trust in the representatives of the patients and providers. Therefore, the final 
meeting was attended by four participants, representing the Dutch Federation of Patients’ 
Organisations (HP), the Dutch College of General Practitioners (TD), the Dutch Association of 
Medical Specialists (IM), and the Dutch Nurses’ Association (SK). They expressed their positive 
intentions with regard to supporting the guidance, but only after the following issues were 
clarified: the minimum criteria should clearly be listed separate from the additional suggestions; 
developers of patient-directed knowledge tools should be encouraged to use the guidance 
according to the comply or explain principle; authorization of patient-related knowledge tools 
should be done on a process level and not on the level of authorizing the content of the tools, as 
content was already authorized in the final phase of the guideline development process.
In retrospect, it can be observed that the quest for clear and outspoken procedural standards 
that was verbalised by some project leaders in WP3 was strongly echoed in the first meeting 
but that it faded away in the second meeting, while only crude instructions for each step were 
regarded sufficient in the third and final meeting. 
The guidance
WP1 provided rich data for formulating eight distinct development steps in the guidance 
(Table 2). The final guidance consists of three components: a) recommendations for which 
type of knowledge tool (such as a lay summary or decision aid) best fits the objectives of 
the development group; b) minimum criteria for the eight development steps, content and 
governance of each tool (Box 2); c) supplemental, detailed and concrete suggestions for each 
step in a second layer of information (14 pages in total, not presented, available on request). 
Developers deviating from these minimum criteria would have to provide a rationale for why a 
criterion does not apply (‘comply or explain’). The steps need not always be followed in linear 
fashion, as the guidance establishes the criteria for an effective development process rather 
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than laying out a strictly prescribed series of ordered steps. In the event that the development 
of the knowledge tool (patient information on a guideline or a patient decision aid based on a 
specific guideline recommendation) is part of a guideline project, the development team will 
ideally be commissioned by the guideline working group itself.
Table 2: The similarities and differences between the eight development steps for a) patient 
information on a guideline and b) a patient decision aid (PDA) connected to specific guideline 
recommendation(s)
Typical of patient information 
on a guideline(s)
DEVELOPMENT STEPS Typical of PDA connected to 
specific recommendation(s)
1 TEAM
Chose members and define tasks
Provides an overview of the 
entire guideline (module)
2 SCOPE
Establish provisional scope
Create inventory of existing 
versions
Concerns one or several specific 
recommendations.
Not a one-to-one application 
of guideline. Information needs 
may also differ from those 
mentioned in the guideline.
3 NEEDS
Identify information needs Establish attributes for 
consideration in decision-making.
Needs of care providers as well.
Purposeful selection of 
guideline recommendations.
4 CONTENT
Content and form International criteria are in 
place; IPDAS (Int. Pat. Dec. Aids 
standards)
5 TEST
Testing the concept
6 FINALISING
Finalising and obtaining approval
7 DISSEMINATION
Dissemination and application
8 OWNERSHIP
Management and revision
For patient versions of guidelines, the patients’ information needs together with the subject 
of the guideline will form the basis for the content of the patient version; the guideline itself 
should be the most important source of information. Rather than assuming just one guideline 
as a starting point, this situation might mean that multiple guidelines will need to be integrated 
and translated into a single patient information document, as this process will more effectively 
address the desires and perceptions of the target group. Or, alternatively, it might mean that 
only a limited number of guideline modules will be applied in creating patient information 
documents. A need to develop one or more patient decision aids is especially indicated when 
one or more of the guideline’s key recommendations are preference-sensitive in nature.
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Box 2: The guidance. A brief description of each step for the development of patient information 
on a guideline or a patient decision aid (PDA) connected to specific guideline recommendation(s).
1 TEAM The team composition is discussed with the relevant patients’ 
and professional associations. The team has an independent chair 
and a process support member/secretary, along with at least one 
patient (-representative) with first-hand experience (acquired by the 
patients’ organisation). Membership of the team is approved based on 
written Declarations of Interests. An editor with experience in writing 
copy for a non-expert audience will be involved in the team. If the 
development of the tool is part of a guideline project, the team will 
(ideally) be commissioned by the guideline working group itself, which 
has budgeted the developmental work.
2 SCOPE The team checks the availability of existing tools, and 
establishes the objective, the target group and the rough form of the 
tool.
Patient information: Determine where the guideline is failing to 
meet patients’ information needs. After all, guidelines for practice 
are typically drawn up from the perspective of the care provider. 
Whenever possible, address the major underlying questions patients 
have about the guideline, as well as the key recommendations.
PDA: Select one or more recommendations from the guideline 
that have to do with the decision at hand, and that are preference-
sensitive in nature.
3 NEEDS There are multiple ways to identify the needs of patients: 
a review of the literature, and/or additional qualitative or quantitative 
methodologies for collecting data, such as focus groups or 
questionnaires.
Patient information: Concerns any additional needs that have not yet 
been elaborated during the guideline development, e.g. with regard 
to multimorbidity, ethnic minorities, alternative interventions, self-
management.
PDA: Involves questions the patients and their proxies may have 
when faced with taking a specific decision. Which needs, preferences 
and attributes influence a given patient’s decision-making? This 
might involve information needs and psychosocial needs, along with 
important strategies for self-management in connection with the 
illness or condition, and should also include the variations between 
patients.
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4 CONTENT For both type of tools describe:
- The target group and medical condition/symptom/healthcare topic.
- The guideline(s) serving as the basis (in part) for the creation of the 
information on evidence, etc.
- The source of funding, who has ownership, year of publication and 
expiry date (if applicable).
- The interests of each member of the development group (conflict 
of interest).
Patient information: 
Describe the guideline recommendations on which patients would 
want to be informed in terms that a layperson can understand. 
Mention frequently-used examples of professional jargon so that 
patients can become familiar with them. The patient information will 
additionally indicate the following aspects:
- Point out where aspects have consciously been omitted and/or 
emphasis has intentionally shifted (if applicable), as compared to 
the guideline.
PDA: 
Describe the situation/decision at hand and the relevant 
recommendation(s) from the guideline, in terms that a layperson 
would understand. The PDA will describe the following aspects (at 
minimum):
- An explanation that the patient has a choice; that he/she is facing a 
preference-sensitive decision.
- A description of the medical/care options, including the option to 
wait and see (if applicable) and an explanation of the procedure for 
each medical/care intervention.
- The desired and undesired outcomes (side effects) of the medical 
or care options, and the burden of treatment.
- The likelihood and risks of the outcomes, expressed as numeric 
data with equal denominator of population in natural frequencies 
and an identical length of time; preferably displayed in population 
diagrams; framed both positively and negatively (chances of both 
survival and fatality, for example); and in the case of risk reduction 
presented, at minimum, in terms of absolute (and potentially 
relative) risk reduction.
- An evidence table in which the medical/care options are 
summarised and compared in terms of a few key aspects.
- Ensure explicit mention of the attributes found in step 3 that 
are important for patients to keep in mind as they consider their 
options and elicit their values. These attributes must contribute to 
the key aspects described in the evidence table.
Valorisation chapter
DunjaDreesens_binnenwerk_def_aangepast.indd   182 25-9-2020   00:42:32
183
5 TEST The development team will present the draft to the relevant 
professional, scientific and patients’ associations for the purpose 
of obtaining feedback. The parties will assess whether the patient 
perspective is sufficiently reflected, ensure understanding of people 
with low literacy, and if the medical content is accurate. If the 
guideline working group is still active, the draft will be presented to 
that group for feedback as well.
6 FINALISING The development team establishes the final knowledge 
tool and presents it to the relevant professional, scientific and 
patients’ associations for approval. This regards approval at the 
process level, i.e. concerning the creation of the knowledge tool. 
Ownership is determined and formally established.
7 DISSEMINATION The tool will ideally be submitted to the national 
Health Care Institute as a section of the relevant guideline(s). The 
knowledge tool becomes accessible to the public and is preferably 
made available at a central location, including points for attention to 
facilitate the actual application/implementation in healthcare practice.
8 OWNERSHIP The owner(s) of the knowledge tool will manage the 
tool and determine when the information is due to be revised: in any 
case when the expiry date has been reached. Ideally, the need for 
revision of the tool will be considered when the guideline as a whole 
is revised.
Discussion
We successfully collaborated as a consortium of researchers and end user representatives, 
with patient participation realised at the highest level of involvement, to achieve formal support 
from national stakeholders on a set of minimum criteria for the development process, content 
and governance of patient-directed knowledge tools related to clinical practice guidelines. What 
we provide is not a detailed ‘recipe’ for development but rather a series of recommendations 
based on the ‘state of the art’ and feasibility considerations. 
A number of potential limitations should be mentioned. Our project was explicitly embedded 
in the guideline context, we did e.g. not include patient versions of systematic reviews. The 
guideline context may be a limiting context for developing patient-directed knowledge tools. 
As the starting point of a clinical practice guideline is predominantly the clinicians’ perspective, 
important issues for patients may not be covered in the guideline. The assignment from the 
National Health Care Institute was aimed specifically at guidelines in the context of curative 
health care. While the literature is unclear in this regard, it is possible that the content of the 
guidance might have been different had representatives from public health, long-term and 
palliative healthcare been included. One strength of this project is the systematic approach 
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and involvement of all national stakeholders, from patients to policymakers, with patient 
representatives in a co-leading role. We believe that the involvement of all stakeholders from 
the writing phase of the project proposal contributed to the successful collaboration. Another 
strength of the project is that the guidance was developed with prospective feasibility checks 
parallel to the nine ongoing development projects. 
The relevance of patient-directed knowledge tools being publicly available has also been 
acknowledged in the UK, with one of the main institutions developing guidelines committed to 
develop patient decision aids based on clinical guidelines28. The relevance of this process was 
recently underpinned by empirical evidence in the Netherlands. The Dutch College of General 
Practitioners launched a non-commercial public website in March 2012 that provides easy 
access to patient versions of guidelines. Since its launch, the website has grown to become one 
of the most visited Dutch healthcare websites. Healthcare usage in primary care seems to have 
decreased by 12% after the launch of the website29.
We expect the criteria to evolve over time as they are further tested through developers using 
patient versions of guidelines and patient decision aids, as well as by adding new tools to the 
guidance. The next challenge will be the effective implementation of the guidance as a further 
step towards ensuring the development of high-quality, reliable and publicly available patient-
directed knowledge tools with the support and acceptance of professional associations (and 
alliances), scientific associations and patients’ organisations. The main stakeholders (the 
Dutch Federation of Patients’ Organisations, the Dutch Association of Medical Specialists, 
the Dutch College of General Practitioners and the Dutch Nurses’ Association) continued in 
working together to translate the guidance into a web-based practical version, and to arrive at 
consensus on a sustainable model for the development, publication, governance and financing 
of patient decision aids. An important follow-up step is to crosslink this guidance to the 
guidance for developers of clinical practice guidelines1.
Formal steps towards accreditation have not been taken yet, the question being whether this 
procedure is needed, and is warranted given the current level of evidence. In December 2016, 
the USA National Quality Forum released national standards for the certification of patient 
decision aids30. The certification criteria are meant to be used for ’complete’ patient decision 
aids, which are standalone, independent tools for patients facing a clinical decision. Our 
guidance, although not formulated along the lines of certification criteria, is highly comparable 
with the USA criteria in terms of content. The only USA criterion that we do not cover is that the 
patient decision aid should report readability levels.
We believe that this study can be seen as an inspirational example for other countries that are 
facing the same challenges with regard to the development and governance of clinician- and 
patient-directed knowledge tools such as guidelines, guideline summaries, patient versions of 
guidelines and patient decision aids.
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